Hepatolife icon

3.0 by Tic Social


Sep 28, 2021

About Hepatolife

It is a product to facilitate the measurement of risk scales

Hepatolife es un producto para facilitar la medición de escalas de riesgo en diversas condiciones de interés.

No es la intención de esta aplicación móvil proporcionar asesoramiento médico específico, sino facilitar a los usuarios información útil para comprender mejor su salud, riesgos y/o condición de interés. La aplicación no entrega información que constituya una opinión o consejo médico y no deben considerarse como tales. Hepatolife le recomienda consultar con un médico calificado para obtener un diagnóstico o calculo del riesgo adecuado y responder a sus preguntas personales antes de tomar cualquier decisión médica.

It is not the intention of this mobile application to provide specific medical advice. This application only provides to users the useful information to better understand their health, risks and / or conditions of interest. The application does not provide information that constitutes a medical opinion or advice and should not be considered as such. Hepatolife recommends that you consult with a qualified doctor to obtain a proper risk assessment or diagnosis and answer your personal questions before making any medical decisions.

What's New in the Latest Version 3.0

Last updated on Sep 28, 2021

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Hepatolife Update 3.0

Requires Android

4.1 and up

Available on

Get Hepatolife on Google Play

Show More

Hepatolife Screenshots

Comment Loading...
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.